Primary resistance of renal adenocarcinoma to 1,2,4-triglycidylurazol (TGU, NSC 332488), a new triexpoxide cytostatic agent--a phase II study of the EORTC early clinical trials group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples